The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valencia, X.
Right arrow Articles by Lipsky, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valencia, X.
Right arrow Articles by Lipsky, P. E.
The Journal of Immunology, 2007, 178: 2579-2588.
Copyright © 2007 by The American Association of Immunologists, Inc.

Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus1

Xavier Valencia2,*, Cheryl Yarboro{dagger}, Gabor Illei{dagger},{ddagger} and Peter E. Lipsky*

* Autoimmunity Branch, {dagger} Office of the Clinical Director National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health, and {ddagger} Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Research/National Institutes of Health, Bethesda, MD 20892

CD4+CD25+ T regulatory cells (Tregs) play an essential role in maintaining immunologic homeostasis and preventing autoimmunity. Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a loss of tolerance to nuclear components. We hypothesized that altered function of CD4+CD25high Tregs might play a role in the breakdown of immunologic self-tolerance in patients with SLE. In this study, we report a significant decrease in the suppressive function of CD4+CD25high Tregs from peripheral blood of patients with active SLE as compared with normal donors and patients with inactive SLE. Notably, CD4+CD25high Tregs isolated from patients with active SLE expressed reduced levels of FoxP3 mRNA and protein and poorly suppressed the proliferation and cytokine secretion of CD4+ effector T cells in vitro. In contrast, the expression of FoxP3 mRNA and protein and in vitro suppression of the proliferation of CD4+ effector T cells by Tregs isolated from inactive SLE patients, was comparable to that of normal individuals. In vitro activation of CD4+CD25high Tregs from patients with active SLE increased FoxP3 mRNA and protein expression and restored their suppressive function. These data are the first to demonstrate a reversible defect in CD4+CD25high Treg function in patients with active SLE, and suggest that strategies to enhance the function of these cells might benefit patients with this autoimmune disease.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health.

2 Address correspondence and reprint requests to Dr. Xavier Valencia, National Institutes of Health, 10 Center Drive, Room 6D44, Bethesda, MD 20892. E-mail address: xvalencia{at}mail.nih.gov

3 Abbreviations used in this paper: Treg, T regulatory cell; SLE, systemic lupus erythematosus; SLEDAI, SLE disease activity index; GITR, glucocorticoid-induced tumor factor receptor.




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
N. Mozaffarian, A. E. Wiedeman, and A. M. Stevens
Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1
Rheumatology, July 23, 2008; (2008) ken256v1.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
P. F. K. Yong, L. Aslam, M. Y. Karim, and M. A. Khamashta
Management of hypogammaglobulinaemia occurring in patients with systemic lupus erythematosus
Rheumatology, July 14, 2008; (2008) ken255v1.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Bonelli, A. Savitskaya, K. von Dalwigk, C. W. Steiner, D. Aletaha, J. S. Smolen, and C. Scheinecker
Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)
Int. Immunol., July 1, 2008; 20(7): 861 - 868.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
B Zhang, X Zhang, F L Tang, L P Zhu, Y Liu, and P E Lipsky
Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus
Ann Rheum Dis, July 1, 2008; 67(7): 1037 - 1040.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
H.-Y. Lee, Y.-K. Hong, H.-J. Yun, Y.-M. Kim, J.-R. Kim, and W.-H. Yoo
Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus
Rheumatology, June 1, 2008; 47(6): 789 - 794.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A Kuhn and M Bijl
Pathogenesis of cutaneous lupus erythematosus
Lupus, May 1, 2008; 17(5): 389 - 393.
[Abstract] [PDF]


Home page
LupusHome page
A La Cava
T-regulatory cells in systemic lupus erythematosus
Lupus, May 1, 2008; 17(5): 421 - 425.
[Abstract] [PDF]


Home page
J. Immunol.Home page
K. Venken, N. Hellings, T. Broekmans, K. Hensen, J.-L. Rummens, and P. Stinissen
Natural Naive CD4+CD25+CD127low Regulatory T Cell (Treg) Development and Function Are Disturbed in Multiple Sclerosis Patients: Recovery of Memory Treg Homeostasis during Disease Progression
J. Immunol., May 1, 2008; 180(9): 6411 - 6420.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Bonelli, K von Dalwigk, A Savitskaya, J S Smolen, and C Scheinecker
Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis
Ann Rheum Dis, May 1, 2008; 67(5): 664 - 671.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M. Vargas-Rojas, J. Crispin, Y Richaud-Patin, and J Alcocer-Varela
Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance
Lupus, April 1, 2008; 17(4): 289 - 294.
[Abstract] [PDF]


Home page
BloodHome page
X. Feng, S. Kajigaya, E. E. Solomou, K. Keyvanfar, X. Xu, N. Raghavachari, P. J. Munson, T. M. Herndon, J. Chen, and N. S. Young
Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro
Blood, April 1, 2008; 111(7): 3675 - 3683.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Rahman and D. A. Isenberg
Systemic Lupus Erythematosus
N. Engl. J. Med., February 28, 2008; 358(9): 929 - 939.
[Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Cuda, S. Wan, E. S. Sobel, B. P. Croker, and L. Morel
Murine Lupus Susceptibility Locus Sle1a Controls Regulatory T Cell Number and Function through Multiple Mechanisms
J. Immunol., December 1, 2007; 179(11): 7439 - 7447.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Lu, A. Wu, L. Tesmer, D. Ray, N. Yousif, and B. Richardson
Demethylation of CD40LG on the Inactive X in T Cells from Women with Lupus
J. Immunol., November 1, 2007; 179(9): 6352 - 6358.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J. C Crispin, V. Kyttaris, Y.-T. Juang, and G. C Tsokos
Systemic lupus erythematosus: new molecular targets
Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii65 - iii69.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Kessel, H. Ammuri, R. Peri, E. R. Pavlotzky, M. Blank, Y. Shoenfeld, and E. Toubi
Intravenous Immunoglobulin Therapy Affects T Regulatory Cells by Increasing Their Suppressive Function
J. Immunol., October 15, 2007; 179(8): 5571 - 5575.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
K. Watanabe, P. N. M. Mwinzi, C. L. Black, E. M. O. Muok, D. M. S. Karanja, W. E. Secor, and D. G. Colley
T Regulatory Cell Levels Decrease in People Infected With Schistosoma mansoni on Effective Treatment
Am J Trop Med Hyg, October 1, 2007; 77(4): 676 - 682.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Borsellino, M. Kleinewietfeld, D. Di Mitri, A. Sternjak, A. Diamantini, R. Giometto, S. Hopner, D. Centonze, G. Bernardi, M. L. Dell'Acqua, et al.
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression
Blood, August 15, 2007; 110(4): 1225 - 1232.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.